NO932097D0 - SOFT PHARMACEUTICAL CAPS CONTAINING LYSINCLONIXINATOG PROCEDURE FOR THEIR PREPARATION - Google Patents

SOFT PHARMACEUTICAL CAPS CONTAINING LYSINCLONIXINATOG PROCEDURE FOR THEIR PREPARATION

Info

Publication number
NO932097D0
NO932097D0 NO932097A NO932097A NO932097D0 NO 932097 D0 NO932097 D0 NO 932097D0 NO 932097 A NO932097 A NO 932097A NO 932097 A NO932097 A NO 932097A NO 932097 D0 NO932097 D0 NO 932097D0
Authority
NO
Norway
Prior art keywords
lysinclonixinatog
procedure
preparation
caps containing
soft pharmaceutical
Prior art date
Application number
NO932097A
Other languages
Norwegian (no)
Other versions
NO932097L (en
Inventor
Carlos A Vasqez
Original Assignee
Roemmers Saicf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roemmers Saicf filed Critical Roemmers Saicf
Publication of NO932097D0 publication Critical patent/NO932097D0/en
Publication of NO932097L publication Critical patent/NO932097L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932097A 1992-06-16 1993-06-09 Soft pharmaceutical capsules containing lysine clonixinate and methods for their preparation NO932097L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219702A DE4219702A1 (en) 1992-06-16 1992-06-16 Pharmaceutical soft capsules containing lysine clonixinate and a process for the production thereof

Publications (2)

Publication Number Publication Date
NO932097D0 true NO932097D0 (en) 1993-06-09
NO932097L NO932097L (en) 1993-12-17

Family

ID=6461132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932097A NO932097L (en) 1992-06-16 1993-06-09 Soft pharmaceutical capsules containing lysine clonixinate and methods for their preparation

Country Status (13)

Country Link
EP (1) EP0574822A1 (en)
JP (1) JPH0665078A (en)
KR (1) KR940000108A (en)
CN (1) CN1037934C (en)
AU (1) AU656078B2 (en)
CA (1) CA2098410A1 (en)
DE (1) DE4219702A1 (en)
FI (1) FI932768A (en)
IE (1) IE930446A1 (en)
IL (1) IL105870A (en)
MX (1) MX9303582A (en)
NO (1) NO932097L (en)
ZA (1) ZA934222B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19849848A1 (en) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral application, spontaneous disintegration with liquid and dosage form and process for its preparation
KR20030042935A (en) * 2001-11-26 2003-06-02 알앤피코리아 주식회사 Clonixin lysinate formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337570A (en) * 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE4037554A1 (en) * 1990-11-26 1992-05-27 Roemmers Sa MEDICAMENT FOR TOPICAL APPLICATION

Also Published As

Publication number Publication date
FI932768A0 (en) 1993-06-16
IL105870A0 (en) 1993-10-20
NO932097L (en) 1993-12-17
ZA934222B (en) 1994-01-17
IE930446A1 (en) 1993-12-29
EP0574822A1 (en) 1993-12-22
AU656078B2 (en) 1995-01-19
CN1083702A (en) 1994-03-16
CN1037934C (en) 1998-04-08
KR940000108A (en) 1994-01-03
DE4219702A1 (en) 1993-12-23
AU4000993A (en) 1993-12-23
FI932768A (en) 1993-12-17
CA2098410A1 (en) 1993-12-17
MX9303582A (en) 1994-04-29
JPH0665078A (en) 1994-03-08
IL105870A (en) 1996-12-05

Similar Documents

Publication Publication Date Title
FI946064A (en) Vaccine composition containing aids
DK647087A (en) SUBSTITUTED BASIC TETRALINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
FI925615A0 (en) PHARMACEUTICAL COMPOSITION OF THE STABILIZER, SOM INNEHAOLLER EN HMG-COA-REDUKTAS-INHIBITORFOERENING
FI954767A (en) Lopophilic drugs containing pharmaceutical composition
NO943044D0 (en) Formulations containing hyaluronic acid
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
BR9408457A (en) Percutaneous pharmaceutical preparation
DE10199046I2 (en) Rapamycin preparations for oral administration
DK488885A (en) 9-AMINO-1,2,3,4-TETRAHYDROACRIDIN-1 OL AND RELATED COMPOUNDS, THEIR PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
FI925633A0 (en) FRAMEWORK FOR THE FRAMEWORK OF THE PHARMACEUTICAL COMPOSITION OF A SELECTIVE SAFETY LIPIDNIVAON I BLODET
DK593883A (en) SUBSTITUTED PHENYLSULPHONYLOXYBENZIMIDAZOLE CARBAMINATES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE
DK539087D0 (en) 4,5-DIHYDRO- AND 4,5,6,7-TETRAHYDRO-PYRAZOLOOE1,5-AAAPYRIMIDINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
NO960272D0 (en) Oxathiolanes, processes for their preparation and pharmaceutical compositions containing the same
DK303688A (en) POLYOXYGENERATED LABORATIVE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
NO930796D0 (en) GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK393788A (en) SUBSTITUTED THIENOIMIDAZOLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DK401988D0 (en) 11-SUBSTITUTED 5-ARYL-5H, 11H-PYRROLO (2,1-C) - (1,4) BENZOXAZEPINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
NO932097D0 (en) SOFT PHARMACEUTICAL CAPS CONTAINING LYSINCLONIXINATOG PROCEDURE FOR THEIR PREPARATION
DK259088A (en) DIARYLALKYL-SUBSTITUTED ALKYLAMINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DK225189D0 (en) HYDRAZINOCARBONYLOXYLABADANES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
NO940533D0 (en) Purified streptogramins, their preparation as well as pharmaceutical preparations containing the compounds
DK37589D0 (en) PHARMACEUTICAL PREPARATION FOR 4-AROYLIMIDAZOLE-2-ONER
FI954348A0 (en) Aluminum controlled release pharmaceutical preparation
FI903885A0 (en) NY ORAL PHARMACEUTICAL DOSERINGSFORM SOM FOERBAETTRAR BIOTILLGAENGLIGHETEN.
FI935826A0 (en) Kallsmoerjmedel med delvis neutraliserade phosphorsyraestrar som EP-tillsatsaemnen